Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

NCT03067610 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Carcinoma, Squamous Cell
Neoplasms, Oral
Neoplasms, Pharyngeal

Interventions

RADIATION: Intensity Modulated Radiation Therapy
DRUG: chemotherapy

Sponsor

University of Texas Southwestern Medical Center